相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapy for Prostate Cancer
Nicholas J. Venturini et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model
Ying-Chun Shen et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Inhibitors of the PD-1 Pathway in Tumor Therapy
Martin W. LaFleur et al.
JOURNAL OF IMMUNOLOGY (2018)
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways
Chao Liang et al.
CELL DEATH & DISEASE (2018)
Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks
Michael C. Comiskey et al.
CURRENT ONCOLOGY REPORTS (2018)
Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells
Kazumi Ebine et al.
SCIENTIFIC REPORTS (2018)
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
Zoila Lopez-Bujanda et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg et al.
CELL REPORTS (2017)
New Strategies in Bladder Cancer: A Second Coming for Immunotherapy
Ali Ghasemzadeh et al.
CLINICAL CANCER RESEARCH (2016)
Epigenetic Therapeutics: A New Weapon in the War Against Cancer
Nita Ahuja et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
Emmanuel S. Antonarakis et al.
ONCOLOGIST (2016)
Cancer immunotherapy targeting neoantigens
Yong-Chen Lu et al.
SEMINARS IN IMMUNOLOGY (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
Alexander S. Baras et al.
ONCOIMMUNOLOGY (2016)
A primer on tumour immunology and prostate cancer immunotherapy
Runhan Ren et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance
A. M. Martin et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Robert D. Leone et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Is CD137 Ligand (CD137L) Signaling a Fine Tuner of Immune Responses?
Byungsuk Kwon
IMMUNE NETWORK (2015)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon et al.
LANCET ONCOLOGY (2014)
Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens
Harm Westdorp et al.
FRONTIERS IN IMMUNOLOGY (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
High tissue density of FOXP3+T cells is associated with clinical outcome in prostate cancer
Anna Flammiger et al.
EUROPEAN JOURNAL OF CANCER (2013)
The Ratios of CD8+ T Cells to CD4+ CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
Claudia C. Preston et al.
PLOS ONE (2013)
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
Sarah Picaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immunotherapy earns its spot in the ranks of cancer therapy
Drew Pardoll et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Barbara Seliger et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line
PA Watson et al.
CANCER RESEARCH (2005)
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
MK Jang et al.
MOLECULAR CELL (2005)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
A Dey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Locus-specific constitutive and cytokine-induced HLA class I gene expression
DR Johnson
JOURNAL OF IMMUNOLOGY (2003)
Molecular characterization of human prostate carcinoma cell lines
A van Bokhoven et al.
PROSTATE (2003)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C
DR Johnson
HUMAN IMMUNOLOGY (2000)
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection
SRM Clarke et al.
IMMUNOLOGY AND CELL BIOLOGY (2000)
分享论文
